Piloting a Novel, Mobile Cognitive Training Tool for Patients With Major Depressive Disorder (MDD)
NCT ID: NCT02922556
Last Updated: 2019-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2015-09-30
2019-06-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology
NCT03067506
Can the Memory Support Intervention Improve Depression Outcome Following Cognitive Therapy?
NCT02938559
Cognitive Training for Depression II
NCT01934491
Cognitive Training for Depression
NCT01936506
Non-invasive BCI and Application Verification for Depressed People
NCT06417437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Treatment
Computerized plasticity-based adaptive cognitive training (Moodify) requiring a total maximum of 50 treatment hours, 3-5 times weekly, 30-45 minutes each session.
Computerized Plasticity-Based Adaptive Cognitive Training
Active Comparator
Commercially available computerized training (Games) requiring a total maximum of 50 treatment hours, 3-5 times weekly, 30-45 minutes each session.
Commercially available computerized training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computerized Plasticity-Based Adaptive Cognitive Training
Commercially available computerized training
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants must be fluent in English
* Participants must be able to engage with computerized cognitive tasks as required in order to participate in this study.
* Normal vision (or corrected to normal vision)
* Participants must be willing to commit to the time requirements of the study as evidenced by written, informed consent.
* Participants must meet diagnostic criteria for MDD
Exclusion Criteria
* Participants unable to perform neuropsychological evaluations
* Participants cannot comprehend or follow instructions
* Participants not capable of giving informed consent
* Participants who appear to be intoxicated or under the influence of a controlled substance
* Participants with a history of significant medical diseases or multiple neurological events of the head
* Participants with serious or unstable medical illness (e.g. cardiovascular, hepatic, renal, endocrine, neurologic disease)
* Participants with a history or current diagnosis to specific Diagnostic and Statistical Manual (DSM)-IV psychiatric illness such as (but not limited to): organic mental disorder, schizophrenia, schizoaffective disorder, delusional disorder, psychotic disorder Not Otherwise Specific, bipolar disorder, substance dependence and substance abuse
* Participants with a history of seizure disorder
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Posit Science Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Posit Science Corporation
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSC-1008-2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.